A detailed history of Fmr LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 114,162 shares of VYGR stock, worth $618,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,162
Previous 96,796 17.94%
Holding current value
$618,758
Previous $327,000 8.56%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$2.73 - $3.64 $47,409 - $63,212
17,366 Added 17.94%
114,162 $355,000
Q1 2025

May 12, 2025

SELL
$3.38 - $6.04 $11,427 - $20,421
-3,381 Reduced 3.38%
96,796 $327,000
Q4 2024

Feb 13, 2025

BUY
$5.27 - $8.07 $40,468 - $61,969
7,679 Added 8.3%
100,177 $568,000
Q3 2024

Nov 13, 2024

BUY
$5.77 - $9.27 $113,218 - $181,895
19,622 Added 26.93%
92,498 $541,000
Q2 2024

Aug 13, 2024

BUY
$7.42 - $10.54 $46,441 - $65,969
6,259 Added 9.4%
72,876 $576,000
Q1 2024

May 13, 2024

SELL
$7.15 - $10.84 $157 - $238
-22 Reduced 0.03%
66,617 $620,000
Q4 2023

Feb 13, 2024

SELL
$6.28 - $8.81 $47,985 - $67,317
-7,641 Reduced 10.29%
66,639 $562,000
Q3 2023

Nov 13, 2023

BUY
$7.55 - $11.25 $27,633 - $41,175
3,660 Added 5.18%
74,280 $575,000
Q2 2023

Aug 11, 2023

BUY
$6.94 - $13.99 $4,830 - $9,737
696 Added 1.0%
70,620 $808,000
Q1 2023

May 11, 2023

BUY
$6.0 - $10.78 $66 - $118
11 Added 0.02%
69,924 $539,000
Q4 2022

Feb 13, 2023

BUY
$4.94 - $6.61 $54 - $72
11 Added 0.02%
69,913 $426,000
Q3 2022

Nov 10, 2022

SELL
$5.57 - $7.47 $557 - $747
-100 Reduced 0.14%
69,902 $414,000
Q2 2022

Aug 12, 2022

SELL
$4.82 - $10.09 $79,168 - $165,728
-16,425 Reduced 19.0%
70,002 $414,000
Q1 2022

May 13, 2022

BUY
$2.75 - $9.44 $237,674 - $815,870
86,427 New
86,427 $659,000
Q4 2021

Feb 14, 2022

SELL
$2.47 - $5.55 $2,887 - $6,487
-1,169 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.63 - $4.12 $625 - $980
238 Added 25.56%
1,169 $3,000
Q2 2021

Aug 13, 2021

BUY
$3.94 - $5.44 $3,668 - $5,064
931 New
931 $3,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $209M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.